• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocular Therapeutix, Inc. - Common Stock (NQ:OCUL)

9.850 -0.260 (-2.57%)
Official Closing Price Updated: 4:15 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,764,641
Open 10.17
Bid (Size) 9.700 (2,000)
Ask (Size) 10.02 (4,000)
Prev. Close 10.11
Today's Range 9.735 - 10.39
52wk Range 6.230 - 16.44
Shares Outstanding 157,749,490
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ocular Therapeutix (OCUL): Buy, Sell, or Hold Post Q1 Earnings?
Today 0:05 EDT
Over the past six months, Ocular Therapeutix’s shares (currently trading at $10.37) have posted a disappointing 18.5% loss, well below the S&P 500’s 7.8% gai... 
Via StockStory
Topics Stocks
News headline image
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
June 18, 2026
Check out the companies making headlines yesterday: Nubank (NYSE:NU): Digital banking platform Nubank (NYSE:NU) rose by 3.2% on Wednesday after the company r... 
Via StockStory
Topics Economy

Performance

YTD
-16.7%
-16.7%
1 Month
+18.8%
+18.8%
3 Month
+21.6%
+21.6%
6 Month
-22.7%
-22.7%
1 Year
+17.7%
+17.7%

More News

Read More
News headline image
Why Ocular Therapeutix (OCUL) Stock Is Up Today
June 17, 2026
Via StockStory
News headline image
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? ↗
June 15, 2026
Via The Motley Fool
Ocular Therapeutix Inc (NASDAQ:OCUL) Misses on Revenue and EPS in Q1 2026, Stock Dips ↗
May 05, 2026
Via Chartmill
News headline image
3 of Wall Street’s Favorite Stocks That Concern Us
June 10, 2026
Via StockStory
News headline image
1 Russell 2000 Stock to Research Further and 2 Facing Headwinds
May 28, 2026
Via StockStory
News headline image
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1 ↗
May 26, 2026
Via The Motley Fool
Topics Regulatory Compliance Stocks
News headline image
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors ↗
May 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Ocular Therapeutix (OCUL) Stock Is Nosediving
May 05, 2026
Via StockStory
News headline image
Ocular Therapeutix (NASDAQ:OCUL) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings
May 05, 2026
Via StockStory
News headline image
Ocular Therapeutix (OCUL) To Report Earnings Tomorrow: Here Is What To Expect
May 03, 2026
Via StockStory
News headline image
1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
April 02, 2026
Via StockStory
News headline image
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools ↗
March 18, 2026
Via The Motley Fool
News headline image
What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down ↗
March 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Cash-Heavy Stock to Research Further and 2 We Brush Off
March 18, 2026
Via StockStory
News headline image
3 Reasons to Avoid OCUL and 1 Stock to Buy Instead
March 17, 2026
Via StockStory
News headline image
3 Stocks Under $10 We Think Twice About
March 16, 2026
Via StockStory
News headline image
Pharmaceuticals Stocks Q4 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
March 11, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Small-Cap Stocks We’re Skeptical Of
March 05, 2026
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We’re Skeptical Of
March 04, 2026
Via StockStory
News headline image
Ocular Therapeutix (OCUL) Stock Trades Down, Here Is Why
February 27, 2026
Via StockStory
Topics Economy Stocks
News headline image
1 Russell 2000 Stock Worth Investigating and 2 We Avoid
February 26, 2026
Via StockStory
News headline image
1 Volatile Stock for Long-Term Investors and 2 Facing Challenges
February 18, 2026
Via StockStory
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
February 17, 2026
Via Chartmill

Frequently Asked Questions

Is Ocular Therapeutix, Inc. - Common Stock publicly traded?
Yes, Ocular Therapeutix, Inc. - Common Stock is publicly traded.
What exchange does Ocular Therapeutix, Inc. - Common Stock trade on?
Ocular Therapeutix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ocular Therapeutix, Inc. - Common Stock?
The ticker symbol for Ocular Therapeutix, Inc. - Common Stock is OCUL on the Nasdaq Stock Market
What is the current price of Ocular Therapeutix, Inc. - Common Stock?
The current price of Ocular Therapeutix, Inc. - Common Stock is 9.850
When was Ocular Therapeutix, Inc. - Common Stock last traded?
The last trade of Ocular Therapeutix, Inc. - Common Stock was at 06/24/26 04:15 PM ET
What is the market capitalization of Ocular Therapeutix, Inc. - Common Stock?
The market capitalization of Ocular Therapeutix, Inc. - Common Stock is 1.55B
How many shares of Ocular Therapeutix, Inc. - Common Stock are outstanding?
Ocular Therapeutix, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap